| 000 | 01519nam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025517.0 | ||
| 008 | 090201s2007 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.03.Ph.D.2007.Ra.P | ||
| 100 | 0 | _aRabab Afifi Mohamed | |
| 245 | 1 | 0 |
_aP53 dysfunction in chronic lymphocytic leukemia / _cRabab Afifi Mohamed ; Supervised Amr Hammam Zeyada , Osaman Mohamed Mansour , Sonya Fahmy Arsanyos |
| 246 | 1 | 5 | _aالإضطراب الوظيفى للعامل ب53 فى مرض سرطان الدم الليمفاوى المزمن |
| 260 |
_aCairo : _bRabab Afifi Mohamed , _c2007 |
||
| 300 |
_a193 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology | ||
| 520 | _aThe aim of this study was to determine p53 dysfunction in CLL patients.In response to chemotherapy as detected by impaired up regulation of p53 and p21 in response to chemotherapy.Determine it p53 dysfunction was caused by Mdm2 over expression | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCLL | |
| 653 | 4 | _aP21 | |
| 653 | 4 | _aP53 dysfunction | |
| 700 | 0 |
_aAmr Hammam Zeyada , _eSupervisor |
|
| 700 | 0 |
_aOsaman Mohamed Mansour , _eSupervisor |
|
| 700 | 0 |
_aSonya Fahmy Arsanyos , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c14562 _d14562 |
||